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New Quantitative Mass Spectrometry
Approaches Reveal Different ADP-ribosylation
Phases Dependent On the Levels of Oxidative
Stress*□S
Vera Bilan‡§, Nathalie Selevsek¶, Hans A. V. Kistemaker, Jeannette Abplanalp‡§,
Roxane Feurer‡, Dmitri V. Filippov, and Michael O. Hottiger‡**
Oxidative stress is a potent inducer of protein ADP-ribo-
sylation. Although individual oxidative stress-induced
ADP-ribosylated proteins have been identified, it is so far
not clear to which extent different degrees of stress se-
verity quantitatively and qualitatively alter ADP-ribosyla-
tion. Here, we investigated both quantitative and qualita-
tive changes of the hydrogen peroxide (H2O2)-induced
ADP-ribosylome using a label-free shotgun quantification
and a parallel reaction monitoring (PRM) mass spectrom-
etry approach for a selected number of identified ADP-
ribosylated peptides. Although the major part of the basal
HeLa ADP-ribosylome remained unchanged upon all
tested H2O2 concentrations, some selected peptides
change the extent of ADP-ribosylation depending on the
degree of the applied oxidative stress. Low oxidative
stress (i.e. 4 M and 16 M H2O2) caused a reduction in
ADP-ribosylation of modified proteins detected under un-
treated conditions. In contrast, mid to strong oxidative
stress (62 M to 1 mM H2O2) induced a significant increase
in ADP-ribosylation of oxidative stress-targeted proteins.
The application of the PRM approach to SKOV3 and
A2780, ovarian cancer cells displaying different sensitivi-
ties to PARP inhibitors, revealed that the basal and the
H2O2-induced ADP-ribosylomes of SKOV3 and A2780 dif-
fered significantly and that the sensitivity to PARP inhib-
itors correlated with the level of ARTD1 expression in
these cells. Overall, this new PRM-MS approach has
proven to be sensitive in monitoring alterations of the
ADP-ribosylome and has revealed unexpected alterations
in proteins ADP-ribosylation depending on the degree of
oxidative stress. Molecular & Cellular Proteomics 16:
10.1074/mcp.O116.065623, 949–958, 2017.
ADP-ribosylation of proteins is a reversible post-transla-
tional modification (PTM)1 in which the ADP-ribose moiety of
NAD is transferred onto a specific amino acid of the ac-
ceptor protein. Intracellular ADP-ribosylation is catalyzed
by diphtheria toxin-like ADP-ribosyltransferases consisting
of 17 members in humans (ARTDs, also known as PARPs)
(1). Whereas many ARTDs catalyze mono-ADP-ribosylation
(MARylation), only ARTD1, ARTD2, ARTD5, and ARTD6 can
extend MAR by attaching additional ADP-ribose units and
producing poly-ADP-ribosylation (PAR) chains (2). Under
steady state conditions, PAR levels are low and hardly de-
tectable (3). The induction of PAR synthesis occurs in re-
sponse to different stress stimuli such as oxidative stress,
DNA damage, and ionizing radiation and is mainly ARTD1
dependent (3). Treatment of cells with hydrogen peroxide
(H2O2), which mimics oxidative stress in cells, induces the
PLC/IP3R/Ca2/PKC signaling cascade to subsequently ac-
tivate nuclear ARTDs (mainly ARTD1) and to induce within a
few minutes PAR formation in the nucleus (4, 5). The half-life
of PARylation is short, and the polymers are quickly degraded
by poly (ADP-ribose) glycohydrolase (PARG).
Cellular ADP-ribosylation has been linked to the develop-
ment of neurodegenerative (6, 7) and metabolic diseases,
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inflammation (8), and tumorigenesis (9). Given the role of
PARylation in various cellular processes such as the geno-
toxic stress response and the identification of ARTD1 as an
important regulator of nuclear chromatin associated ADP-
ribosylation, ARTD1 is an interesting cellular target for phar-
macological interventions. Based on two seminal papers,
which provided evidence that inhibitors of ADP-ribosylation
(i.e. PARP inhibitors, PARPi) can kill tumor cells deficient for
BRCA1-regulated homologous recombination (10, 11), sev-
eral PARP inhibitors have been tested in clinical studies
mainly for the treatment of BRCA1- and BRCA2-deficient
cancer types (12). After succeeding in clinical studies, the
third generation of PARPi was recently approved for the treat-
ment of specific types of ovarian and prostate cancer (13).
However, the response to PARPi treatment is difficult to pre-
dict based on the cancer cells’ BRCA status only. Indeed,
some BRCA-proficient tumors with other mutations have been
described to be sensitive to PARPi, whereas some BRCA-
deficient tumors appear resistant to PARP inhibitor treatment
(14). Thus, understanding the functional role of PARylation and
identifying proteins and their quantitative changes that are ADP-
ribosylated under different stress conditions would represent a
major step forward toward effectively predicting potential PARPi
treatment outcomes in patients.
Recently, Martello et al. developed a MS-based method to
quantify PAR chains from cells and tissues and reported that
PAR chain length increased proportionally to the level of
oxidative stress applied to the cells (15). However, this
method does not allow the identification of the modified pro-
teins and their acceptor sites. The recently developed ADP-
ribosylation specific enrichment methods in combination with
MS/MS analysis overcame this hurdle and allowed the iden-
tification of the cellular ADP-ribosylome under various stress
conditions including oxidative stress (16–18). Although the
H2O2-induced ADP-ribosylome has been characterized (16–
18), it is still not clear whether the numbers of ADP-ribosylated
molecules and/or modified sites of a given protein vary with
stress intensity. Understanding the quantitative and qualita-
tive changes of protein ADP-ribosylation will provide valuable
insights into stress signaling events and reveal the functional
importance of ADP-ribosylation during oxidative stress.
The development of targeted proteomics methods signifi-
cantly improved MS-based quantification of proteins (19, 20).
Selected reaction monitoring (SRM) as well as parallel reac-
tion monitoring (PRM) provide exceptional sensitivity and re-
producibility in comparison to shotgun measurements (21,
22). In a targeted method, the MS instrument selects a set of
precursor ions with a defined m/z from MS1 for subsequent
fragmentation in the collision cell and the resulting fragment
ions are used for protein quantification. Typically, 50 to 100
proteins can be measured in one single MS run (20, 23). The
high sensitivity and reproducibility of PRM measurements
were already successfully applied to study various PTMs (24–
26), e.g. ubiquitination even without an enrichment step (27).
Here, we report both quantitative and qualitative changes of
protein ADP-ribosylation in cells exposed to non-lethal oxida-
tive stress by using both shotgun and specifically developed
PRM approaches for the analysis of selected ADP-ribosylated
acceptor sites induced by oxidative stress.
EXPERIMENTAL PROCEDURES
Experimental Design and Statistical Rationale—The study aimed to
define the quantitative and qualitative levels of ADP-ribosylation un-
der various degrees of oxidative stress. HeLa cells were used as a
model system to determine a basal and oxidative stress-induced
ADP-ribosylome. Label-free quantification (LFQ) and PRM were used
to analyze quantitative changes of ADP-ribosylated peptides. The
ADP-ribosylated H2B-like standard peptide was used as an internal
control to evaluate the variability between measurements. The PRM
method reproducibility was controlled by a technical triplicate of a
250 M H2O2-treated HeLa sample, which was divided into three
parts and enriched in parallel (see Supplementary material, supple-
mental Fig. S1). This control experiment revealed a high reproducibil-
ity of the PRM method (CV  0.059). All further quantitative PRM
experiments were performed in biological duplicates. The different
samples were tested for significant differences by using an ANOVA
test comparing oxidative stress-induced samples to each other and
to an untreated control. Only changes  2-fold were further
considered.
Cell Culture—HeLa cells were cultured in DMEM (GIBCO, Thermo
Fisher Scientific, Waltham, MA) (substituted with 10% FCS and pen-
icillin/streptomycin) at 37 °C and 5% CO2. SKOV3 and A2780 were
grown in RPMI1640 (supplemented with 10% FCS and 1% penicillin/
streptomycin) at 37 °C and 5% CO2.
Synthesis of H2B-like Standard ADP-ribosylated Peptide—The
synthesis of the peptide was described in (28). The schematic chem-
ical structure of the peptide can be found in supplemental Fig. S1A
and has the following sequence: Acetyl-Pro-Gln(ADPr)-Pro-Ala-Lys-
Ser-Ala-Pro-Ala-Pro-Lys-Lys-Gly-NH2. The non-modified peptide
was synthesized as described in (28) and has the following sequence:
Acetyl-Pro-Gln-Pro-Ala-Lys-Ser-Ala-Pro-Ala-Pro-Lys-Lys-Gly-NH2.
Enrichment of ADP-ribosylated Peptides from HeLa Cell Ly-
sate—To induce PAR formation, cells were treated with various con-
centrations of H2O2 for 10 min and lysed in lysis buffer (50 mM Tris
pH 8, 1% Nonidet P-40, 400 mM NaCl, 1 mM EDTA, 0.1% sodium
deoxycholate, complete protease inhibitor mixture (Roche, Mann-
heim, Germany), 10 M PJ34, 75 M tannic acid). After lysis and
acetone precipitation, extracted proteins were digested with trypsin
(cleaves C-terminal to arginine and lysine, Promega, Madison, WI)
and the obtained peptide mixture enriched as described (18) with the
following modifications. The total protein lysate concentration used
for each enrichment was 20 mg for shotgun and 5 mg for PRM
measurements. 100 ng of the ADP-ribosylated H2B-like standard
peptide was spiked into the samples used for quantitative studies
before the Af1521 pulldown. The binding of the H2B-like standard
peptide to Af1521 was validated with SDS-PAGE and Western blot
analysis (supplemental Fig. S1 and supplementary Methods).
Immunofluorescence—Immunofluorescence staining for PAR was
performed as described in Weber et al. (2013) using a homemade 10H
anti-PAR antibody. Oxidative stress was induced by H2O2 treatment
for 10 min (unless otherwise indicated) at the indicated concentra-
tions in PBS, 1 mM MgCl2. The images were taken using a Leica DMI
6000B microscope and processed with ImageJ software (v. 1.6.0).
Liquid Chromatography and Mass Spectrometry Analysis—Mass
spectrometry analysis was performed on an Orbitrap Q Exactive HF
mass spectrometer (Thermo Fisher Scientific) coupled to a nano
EasyLC 1000 (Thermo Fisher Scientific). The peptides were loaded
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onto a self-made column (75 m  150 mm) which was packed with
reverse-phase C18 material (ReproSil-Pur 120 C18-AQ, 1.9 m, Dr.
Maisch GmbH) and connected to an empty Picotip emitter (New
Objective, Woburn, MA). The peptides were separated at a flow rate
of 300 nL/min by a gradient from 2 to 25% B in 90 min. Solvent
composition at the channels A and B was 0.1% formic acid and 0.1%
formic acid, 99.9% acetonitrile, respectively.
To perform shotgun measurements, the mass spectrometer was
set to acquire full-scan MS spectra (300–1700 m/z) at a resolution of
60,000 after accumulation to an automated gain control (AGC) target
value of 3  106. Charge state screening was enabled, and unas-
signed charge states, and single charged precursors were excluded.
Ions were isolated using a quadrupole mass filter with a 2 m/z isola-
tion window. A maximum injection time of 110 ms was set. HCD
fragmentation was performed at a normalized collision energy (NCE)
of 28%. Selected ions were dynamically excluded for 20 s.
For PRM measurements, the Q Exactive HF was set to perform
MS1 scans (350–1000 m/z) followed by 12 MS/MS acquisitions in
PRM mode. HCD fragmentation was conducted at a normalized
collision energy (NCE) of 28%. The full MS scan was carried out with
an AGC target of 105 and at a 60,000 resolution. Maximum injection
time was set to 110 ms. The subsequent PRM MS/MS scans were
performed with an AGC target of 3  106 and at a 60000 resolution
with an isolation window of 2 m/z. Maximum injection time was set to
15 ms. PRM measurements were performed in a time scheduled
mode. The isolation lists for each performed method can be found in
supplemental Tables S3, S4, and S5.
Shotgun Data Analysis—The raw file processing and the database
search using Mascot were conducted as described in (30) with further
indicated modifications. Briefly, MS and MS/MS spectra were con-
verted to Mascot generic format (MGF) using Proteome Discoverer,
v2.1 (Thermo Fisher Scientific). The MGFs were searched against the
UniProtKB human database (taxonomy 9606, version 20140422),
which included 35787 Swiss-Prot, 37802 TrEMBL entries, 73589
decoy hits, and 260 common contaminants. Mascot 2.5.1.3 (Matrix
Science) was used for peptide sequence identification using previ-
ously described search settings. Briefly, peptide tolerance was set to
10 ppm and the MS/MS tolerance to 0.05 Da. False discovery rates at
the peptide and protein level were analyzed with decoy hits. Enzyme
specificity was set to trypsin and up to four missed cleavages were
allowed. The following modifications were searched: carbamidom-
ethylation (C, fixed), oxidation (M, variable), ADP-ribosylation (K, R, D,
E, variable). A Mascot score 20 and an expectation value 0.05
were considered to identify the correctly assigned peptides. The
ADP-ribosylation sites with a site localization confidence of 95%
were considered as correctly assigned (31).
Progenesis QI software (Nonlinear Dynamics, Purham, NC) was
used to perform label-free quantification based on the MS1 precursor
peak area. Raw data were imported into the Progenesis QI (v.
3.0.6039.34628) and aligned based on the MS1 peak retention time.
All samples were normalized based on the total signal intensity to
account for sample loading variations. The obtained results were
exported as MGF and searched with Mascot as indicated above. The
Mascot search results were imported into Scaffold software (v.4.7.2)
and filtered for protein and peptide FDR values of 0.01. When multiple
precursors were observed for the same peptide, the values were
summed up to obtain the total level of the peptide.
PRM Data Analysis Using Skyline—The acquired PRM raw files
were imported into Skyline daily (v.3.5.1.9942). ADP-ribosylation was
defined as H21C15N5O13P2 with 249.0862 and 347.0631 neutral
losses for K, R, D, E, and Q. For each targeted peptide, the precursor
and the 5 most intense fragment ions were monitored and used for
quantification.
The mProphet algorithm was used for automatic peak picking. The
second best peak model was trained using samples treated with 64
M of H2O2. The Q value was set to 0.1. Peaks were manually
checked for correct integration. The peaks that were automatically
assigned for 60% samples were considered as correctly identified,
the wrongly assigned peaks in these cases were integrated manually
using the corresponding retention times and the relative fragment
ions intensity from the library. The area under the curve (AUCs) of
each transition was summed up to obtain the AUCs of the peptide.
When several precursors were monitored for one peptide, the AUCs
of these precursors were summed up.
To evaluate protein abundance changes in ovarian cancer cell
lines, 5 unique tryptic peptides with no miscleavages and carrying
no variable modifications were selected from the SRM Atlas (http://
www.srmatlas.org). The SWATH Atlas (32) was used to obtain
the fragmentation information and retention time for each peptide.
The peptides with no library hits were excluded from the analysis. The
statistical data analysis was performed with the R package “R for
Proteomics” using R studio (v.0.99.903, R (v 3.2.4)) and using the
Perseus software (v.1.5.5.3). GO analysis (cellular localization) was
determined using the UniProt protein name and the CellWhere appli-
cation (http://cellwheremyology.rhcloud.com).
Data Deposit—All MS raw files and Scaffold files presented
in this study can be accessed at MassIVE (MSV000080334,
ftp://massive.ucsd.edu/MSV000080334)
RESULTS
H2O2 dose-dependent PAR formation reaches maximum
levels at 10 min in HeLa cells—To gain more molecular in-
sights into PAR formation and to identify the time for maximal
PAR formation in cells, HeLa cells were treated with 1 mM
H2O2 for four different time points (0, 10, 15, 30 min) and PAR
induction was analyzed via immunofluorescence with 10H
PAR antibody (supplemental Fig. S2A). As the H2O2-induced
ADP-ribosylome of HeLa cells was successfully identified
without the need of a PARG knockdown (17, 18), we used
these cells as a model system to better understand the quan-
titative changes of protein ADP-ribosylation following oxida-
tive stress. The maximal PAR signal was detected after 10 min
H2O2 treatment (supplemental Fig. S2A). To confirm this result
we quantified the modification dynamics of specific ADP-
ribosylated peptides in HeLa cells treated with 500 M H2O2
for 0, 5, 10, 30, 60 min using a SILAC MS approach (supple-
mental Fig. S2B) (18). These experiments confirmed that the
highest level of ADP-ribosylation in HeLa cells is at 10 min. We
thus performed all following experiments at this time point.
To determine whether the observed cellular ADP-ribosyla-
tion is concentration-dependent, PAR formation was moni-
tored in HeLa cells treated for 10 min with increasing concen-
trations of H2O2 (0, 62.5, 250 M, and 1 mM). PAR-specific
immunofluorescence was observed for all tested H2O2 con-
centrations, although the PAR signal intensity steadily in-
creased with the applied concentration of H2O2 (supplemental
Fig. S2C). The differential PAR signal intensities could result
from (i) increased PAR chain length of previously modified
proteins, (ii) increased de novo ADP-ribosylation of previously
unmodified protein types, or (iii) an increase in the number of
ADP-ribosylated molecules belonging to a previously already
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modified protein type (supplemental Fig. S2D). Martello et al.
observed previously a similar correlation between PAR chain
length measured by LC-MS/MS and the level of oxidative
stress, indicating that the observed changes in signal intensities
can be at least partially explained by the growth of PAR chains
(15). However, these results and the limitations of the here
performed immunofluorescence analysis with the 10H PAR an-
tibody, which only binds PAR chains containing at least 3–4
ADP-ribose units (33), do not allow addressing potential
changes of the ADP-ribose acceptor sites (scenarios ii and iii).
The H2O2-induced Changes in the ADP-ribosylome Re-
main Qualitatively Stable With Increasing H2O2 Concentra-
tions—To investigate whether different degrees of oxidative
stress would induce qualitatively different ADP-ribosylomes
(i.e. severity dependent ADP-ribosylation) HeLa cells were left
either untreated or treated with increasing concentrations of
H2O2 (62 M, 250 M, and 1 mM; n  3). Cells were subse-
quently lysed in presence of PARP and PARG inhibitors to
avoid lysis induced ADP-ribosylation. The ADP-ribosylated
peptides were enriched using the Af1521 macrodomain and
proteins were identified by shotgun MS analysis (18). Al-
though untreated HeLa cells showed no detectable PAR sig-
nal by immunofluorescence (supplemental Fig. S2A and S2C),
the shotgun MS approach identified 25 ADP-ribosylated pro-
teins (Fig. 1A), suggesting that already in untreated cells pro-
teins are ADP-ribosylated. To test whether the basal ADP-
ribosylome was dependent on ARTDs, we repeated the
analysis of untreated cells including the cells which were
pretreated before cell lysis for 30 min with PARPi PJ34, which
mainly inhibits PARylation (34). The shotgun MS analysis of
H2O2 untreated but PJ34 pre-treated HeLa cells (n  2) re-
vealed that 9 ADP-ribosylated proteins remained ADP-ribosy-
lated despite PARPi PJ34 in HeLa cell extracts.
Next, we compared the ADP-ribosylomes identified in cells
treated with different H2O2 concentrations (62 M, 250 M,
and 1 mM) to the untreated control and between each other.
Overall, treatment of HeLa cells with H2O2 increased the
number of identified ADP-ribosylated peptides when com-
pared with untreated HeLa cells (Fig. 1A, 1B, and supplemen-
tal Table S1). In total, 83 proteins and 169 sites carrying
ADP-ribose were identified using our shotgun MS approach
following treatment with H2O2. When comparing the ADP-
ribosylomes induced by different H2O2 concentrations, the
overlap of identical modified proteins was 52% (i.e. observed
for at least two H2O2 concentrations, Fig. 1A). Considering the
moderate reproducibility of shotgun MS measurements, which
usually peaks at 60% (35), we concluded that the observed
H2O2-induced ADP-ribosylome sample variation (with 52%
overlap) does not vary substantially, suggesting that the num-
bers of H2O2-induced ADP-ribosylation sites do not change
upon different severities of oxidative stress (Fig. 1B).
The H2O2-induced ADP-ribosylome Does Not Quantitatively
Change at Mid and High H2O2 Concentrations—Our shotgun
MS experiment revealed that H2O2 treatment of HeLa cells
induces qualitatively comparable ADP-ribosylomes. To un-
derstand if the dose-dependent induction of ADP-ribosylation
signal observed by immunofluorescence following H2O2
stress was caused by a gradually increased number of ADP-
ribosylated molecules of a given protein (i.e. quantitative level
of ADP-ribosylation; scenario ii at supplemental Fig. S2D) in
HeLa cells, we performed label-free quantification (LFQ) on
our shotgun samples (HeLa treated with 0–1 mM H2O2). In
total, 83 different proteins with 128 unique ADP-ribose accep-
tor sites were reliably quantified across all samples (Fig. 1C,
supplemental Table S2). By comparing the MS1 intensities of
ADP-ribosylated peptides between the different H2O2 con-
centrations and untreated cells, two groups of ADP-ribosy-
lated proteins were identified.
The first group contained 55 proteins comprising 82 ADP-
ribose acceptor sites that were already modified under un-
treated (basal) conditions and did not significantly change
with increasing H2O2 concentrations (Fig. 1C and 1D, stable)
Many of these identified proteins were already identified in
untreated HeLa cells with the shotgun approach (Fig. 1A, 1C,
and 1D). Although some proteins, like H2B histone variants
and ARTD1, showed a tendency of increased ADP-ribosyla-
tion, the ADP-ribosylation status of these proteins was not
significantly regulated by H2O2 signaling.
The second group contained 38 proteins comprising 46
ADP-ribose acceptor sites, that under basal conditions were
only to a minor part already ADP-ribosylated, but showed a
quantitative increase of ADP-ribosylation starting at 62 M
H2O2, and increased although not significantly until 250 M
H2O2 to reach a plateau (Fig. 1C and 1E). This group con-
tained nuclear proteins, including already known ADP-ribo-
sylation targets like YY1, TOP1, and CTCF. Although the
ADP-ribosylation of these proteins was H2O2-dependent (sig-
nificantly induced comparing untreated to 62 M H2O2), there
was no further significant quantitative increase in the amount
of detectable modified peptides when cells were treated
with higher concentrations of H2O2 (Fig. 1C and 1E), indicat-
ing that already at 62 M H2O2 the oxidative-induced ADP-
ribosylome is established. This data therefore provides strong
evidence that the observed increase in the PAR signal by
immunofluorescence was mainly the result of PAR elongation
rather than an increase in the number of modified proteins.
Protein ADP-ribosylation Required At Least Mid H2O2 Con-
centration—Martello et al., detected PAR formation starting at
a minimal concentration of 10 M H2O2 (15). We thus repeated
our immunofluorescence analysis in HeLa cells using 4 M
and 16 M H2O2 (i.e. mild conditions). Although 16 M H2O2
induced a weak, but detectable PAR formation, PAR forma-
tion with 4 M H2O2 was hardly detectable, indicating that the
extent of PARylation is neglectable under these conditions
(Fig. 2A). However, the activation of cellular oxidative stress
signaling was already occurring at these low concentrations
of H2O2 as shown by the detection of stress markers such as
p-ERK1/2 or p-p38 (supplemental Fig. S3A).
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FIG. 1. Quantification of the oxidative stress-induced HeLa ADP-ribosylome identified two groups of ADP-ribosylation changes. A,
The Venn diagram shows the overlap between the ADP-ribosylated proteins of HeLa cells under untreated (n  5) and PJ34 pre-treated (n 
2) conditions. The identification was performed by shotgun measurements. B, The Venn diagram shows the overlap between the HeLa samples
treated with indicated concentrations of H2O2 (n  3) identified by shotgun. C, The heatmap represents the changes in ADP-ribosylated
peptides in HeLa cells exposed to the indicated concentrations of H2O2 detected using LFQ MS measurement (n  3). The identified
ADP-ribosylome was divided into two groups (‘stable’ and ‘induced’, shown on the right with vertical lines) based on the differences between
H2O2-treated and untreated samples. The induced group contained proteins that showed a significant up-regulation of ADP-ribosylation upon
H2O2 treatment with the lowest tested dose (62 M versus untreated, ANOVA, p  0.05). The values were log2 transformed. D, Examples of
quantitative changes of ADP-ribosylated proteins from the stable group. The average of three measurements and standard deviations after log2
transformation are shown. E, Examples of quantitative changes of ADP-ribosylated proteins from the induced group. The average of three
measurements and standard deviations after log2 transformation are shown.
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To ensure reliable and reproducible measurements of pro-
tein ADP-ribosylation across the samples, and to increase the
sensitivity of the measurements (21), we developed a targeted
MS-based method for defined protein ADP-ribosylation
based on a PRM approach. The protein candidates were
selected from our LFQ measurements and included 71 pro-
teins (133 ADP-ribose acceptor sites). After assay develop-
ment (see supplementary Information), our PRM method tar-
geted 66 proteins and 113 ADP-ribose acceptor sites (see
supplemental Table S3 for PRM method).
Next we preformed PRM measurements on ADP-ribosy-
lated peptides enriched from HeLa cells exposed to 4 M, 16
M and 64 M H2O2. To monitor the efficiency of the enrich-
ment workflow, we added a standard H2B-like ADP-ribosy-
lated peptide (supplemental Fig. S1) in each protein isolate
that we monitored by PRM. In total, we reliably quantified 47
proteins with 60 ADP-ribosylated peptides. Based on the
measured quantitative ADP-ribosylation changes, the ana-
lyzed peptides clustered into three groups (Fig. 2B and sup-
plemental Fig. S3B and S3C). The first group included 9
proteins with 13 ADP-ribosylated peptides, which were al-
ready strongly ADP-ribosylated under basal conditions and
remained modified for all the H2O2 concentrations tested (e.g.
ARTD1 and PDIA3; compare with Fig. 1A). Some proteins in
this group showed a trend of reducing ADP-ribosylation
states at 4 and 16 M H2O2, but reaching the levels observed
under untreated conditions at 64 M H2O2. Histone H2B vari-
ants were among these proteins. This group also contained
PDIA3 and P4HB (also known as PDIA6), the ER proteins that
are stably modified in untreated cells and were identified to
maintain their ADP-ribosylation level in our LFQ measure-
ments (Fig. 2B).
The second group contained 17 proteins with 23 ADP-
ribosylated peptides and at first resembled the first group in
their ADP-ribosylation profile (i.e. was detectable under basal
conditions, and reduced at 4 M or 16 M H2O2), but was
strongly induced at 64 M H2O2 (Fig. 2B and supplemental
Fig. S3B and S3C). Proteins belonging to the third group (26
proteins with 26 ADP-ribose acceptor sites) were not ADP-
ribosylated under untreated conditions or at low H2O2 con-
centrations (4 M or 16 M), but showed robust ADP-ribosyl-
ation at 64 M H2O2 (e.g. MECP2, BAZ1A, HDGF). GO
analysis revealed that this group is significantly (p  0.0132)
enriched for proteins with chromatin and transcription factor
binding capacities. Five of the identified proteins (e.g.MECP2
and CTCF) act as transcriptional co-repressors. The robust
induction of ADP-ribosylation only at 64 M H2O2 suggests
that for the modification of proteins in group 2 and 3 a certain
level of oxidative stress is required (supplemental Fig. S3B).
We validated the results by preparing an additional biological
replicate, and the results were comparable to the first meas-
urement (supplemental Fig. S3D).
The Basal and H2O2-induced ADP-ribosylomes of SKOV3
and A2780 Differ—Next, we applied our newly developed
PRM method to two pathophysiologically relevant ovarian
cancer cell types SKOV3 and A2780, which have been de-
scribed as PARPi-resistant and -sensitive, respectively (36).
These two cell lines were treated with three different PARPi
(Veliparib, Talazoparib, Olaparib) and an MTT metabolic assay
was performed to confirm the reported PARPi sensitivity. In-
deed, A2780 cells were found to be sensitive to lower doses of
all three tested PARPi whereas higher doses were required to
reduce the metabolic activity of SKOV3 cells (supplemental Fig.
S4A).
FIG. 2. Significantly regulated ADP-ribosylated peptides in HeLa cells treated with low dose of H2O2 (4–64 M). A, Immunofluores-
cence analysis of HeLa cells treated for 10 min with the indicated concentrations of H2O2. Cells were stained with DAPI and PAR 10H antibody.
Scale bars: 25 m. B, The heatmap shows the significantly regulated ADP-ribosylated sites of HeLa cells at a low dose of oxidative stress
detected using PRM MS measurement (ANOVA, p  0.05). The colored vertical lines indicate the “stable” (green) and “reduced” (red) groups
of ADP-ribosylated proteins (n  2). The values were log2 transformed.
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To test whether the detectable ADP-ribosylomes in un-
treated and H2O2 treated cancer cells correlate with their
differential PARPi-sensitivity (36), we analyzed the ADP-ribo-
sylation in SKOV3 and A2780 using our PRM method (see
supplemental Table S4 for PRM method) under basal and
H2O2 treated conditions (16 M and 64 M; n 2). Out of the 66
proteins targeted, we reliably quantified 27 proteins with 36
ADP-ribosylated peptides (Fig. 3A and supplemental Fig. S4B)
under basal conditions. Although the histone H2B variants 1-B
and 1-D were ADP-ribosylated at the same level under un-
treated conditions for SKOV3 and A2780 cells, the ADP-ribo-
sylation state of the 1-K variant was 7.4-fold higher in SKOV3
cells (Fig. 3B). In addition to the identified differences in the
modification states of H2B histone variants, YY1, RFC1 and
C11orf58 were ADP-ribosylated in A2780 cells but not in
SKOV3 cells.
Upon H2O2 treatment 27 ADP-ribosylated peptides (out of
36 quantified) were significantly up-regulated in both SKOV3
and A2780 cells independent of the H2O2 concentration used
(Fig. 3A, ANOVA test, p  0.05). Although the ADP-ribosy-
lated peptides from A2780 showed moderate but gradual
increases in their ADP-ribosylation levels in response to in-
FIG. 3. Differences in the ADP-ribosylation level in ovarian cancer cells at basal and H2O2-treated conditions. A, The heatmap shows
the significantly regulated ADP-ribosylated proteins in oxidative stress in two different ovarian cancer cell lines (A2780 and SKOV3) (n  2,
ANOVA, p  0.05), detected using PRM MS measurement. The values were log2 transformed. B, The ADP-ribosylation level of H2B histone
variants for SKOV3 and A2780 detected at basal/untreated condition detected using PRMMSmeasurement. The values were log2 transformed
(n  2). C, Examples of oxidative stress-induced ADP-ribosylated targets for A2780 and SKOV3 at different concentrations of H2O2 detected
using PRM MS measurement. The values were log2 transformed and plotted separately, the dashed lines connect the average values (n  2).
D, The level of ARTD1 in A2780 and SKOV3 cells (n  6, mean  S.D., student t test, p  0.000083), detected using PRM MS measurement.
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creasing H2O2 concentrations, the modified proteins identi-
fied in the SKOV3 cells reached the maximum of detectable
ADP-ribosylation levels already at low H2O2 concentrations
(16 M; Fig. 3C). In contrast, for 20 ADP-ribosylated peptides
(17 proteins) the ADP-ribosylation levels were significantly
higher in A2780 than in SKOV3 cells following 64 M H2O2
treatment (ANOVA test, p  0.05). In summary, we found a
slightly different ADP-ribosylation pattern in response to H2O2
in PARPi-sensitive A2780 cells compared with PARPi-resist-
ant SKOV3 cells (supplemental Fig. S3C).
The resistance to PARP inhibitors negatively correlates with
the abundance of ARTD1—Potentially, the observed different
levels of ADP-ribosylation could be explained by differential
abundance of the analyzed proteins. Thus, we evaluated the
overall abundance of the ADP-ribosylated proteins by per-
forming PRM measurements targeting 3–5 peptides per pro-
teins, which were found to be ADP-ribosylated in our first
PRM cancer cell line measurement (see supplemental Table
S5 for PRMmethod). This experiment revealed that the overall
protein abundance was not altered and was very comparable
in the tested cell lines (supplemental Fig. S4C) whereas, in-
terestingly, the level of ARTD1 in SKOV3 cells was 30% lower
compared with A2780 (Fig. 3D). Unfortunately, because of the
high sequence similarities, we were unable to evaluate the
abundance of the specific H2B variants.
DISCUSSION
Here, we analyzed with newly developed MS-based ap-
proaches the quantitative and qualitative changes of the cel-
lular ADP-ribosylome in response to treatment with different
H2O2 concentrations.
We first evaluated the qualitative characteristics of ADP-
ribosylomes for different H2O2 concentrations, and found that
the identified ADP-ribosylomes are comparable, indicating
that upon H2O2 treatment nuclear ARTDs reproducibly modify
a pre-defined set of proteins involved in the oxidative stress
response. To perform the quantitative evaluation, we applied
label free quantification which led to the development of an
oxidative stress-tailored PRM approach. Based on the iden-
tified quantitative changes of the ADP-ribosylome, ADP-ribo-
sylated proteins can be divided into a basal (i.e. H2O2-inde-
pendent) and a H2O2-signaling dependent group. The basal,
H2O2-independent group maintained its modification level
with all tested H2O2 concentrations and contained ADP-ribo-
sylated proteins localized to various cytoplasmic compart-
ments. Notably, seven of the identified proteins localized to
the endoplasmic reticulum (ER), among them three protein
disulfide isomerases (PDIA1, 3, and 6) which were found to be
ADP-ribosylated on arginines and are likely to be involved in
the unfolded protein response. Interestingly, several ARTs
also have been implicated in the unfolded protein response,
i.e. ARTD15 (37) and ARTC1 (38). However, the potential
writers of these and other basal ADP-ribosylated sites have to
be identified and confirmed. Many of the identified ADP-
ribosylation sites at basal conditions were insensitive to PJ34
pretreatment, indicating that they are either modified by PJ34
insensitive ARTs or that their erasure takes longer than 30 min
(the time of PJ34 pre-treatment), thus shifting the cellular
state of these ADP-ribose acceptor sites to the modified form.
Under basal conditions, HeLa show no PAR staining, sug-
gesting that the ADP-ribosylated sites detected in untreated
cells are most probably MARylated. Unfortunately, because of
the PARG treatment step required during the enrichment pro-
tocol, it is currently not yet possible to experimentally distin-
guish between PARylation or MARylation. Finally, the H2O2-
independent group contained 35 proteins which localized to
the nucleus. These proteins showed increased numbers of
ADP-ribosylated peptides when treated with 64 M H2O2,
however, the changes were not significant. Potentially, these
sites are regulated by H2O2, but because of either technical or
biological variability failed to reach significance.
ADP-ribosylation in the second group of proteins was in-
duced by H2O2 treatment and its extent was H2O2 concen-
tration-dependent, although this response is more complex
as expected. When HeLa cells were exposed to mid oxidative
stress (i.e. 64 M H2O2), we observed a significant increase in
the quantity of ADP-ribosylated proteins compared with un-
treated cells. However, the numbers of modified peptides did
not quantitatively change when the oxidative stress was in-
creased further from 64 M up to 1 mM H2O2. The relatively
stable levels of ADP-ribosylation (quantitatively and qualita-
tively) indicate that upon treatment by H2O2 nuclear ARTDs
modify only a specific set and amount of proteins.
Interestingly, low oxidative stress (i.e. 4 and 16 M H2O2)
either did not induce ADP-ribosylation (i.e. sites were not
detected at basal condition and mild oxidative stress) or even
decreased it (sites were detected under basal condition but
lost the modification in mild oxidative stress), although phos-
phorylation of p38 could be observed under these conditions
(supplemental Fig. S3A). There are several possible explana-
tions for the reduction of ADP-ribosylation levels at mild oxi-
dative stress. First, low H2O2 doses could induce the activity
of ADP-ribose (glyco)hydrolases, e.g. PARG, that would de-
modify existing basal ADP-ribosylation. The enzymatic ac-
tivity of this class of enzymes remains poorly understood, and
further investigations are needed to substantiate this possi-
bility. Alternatively, H2O2 stimulation might activate different
signaling pathways, which could lead to the induction of other
PTMs. In this case, the peptides might gain an additional
mass shift, making them undetectable using our PRM
method. At high concentration of H2O2, ADP-ribosylation
would be strongly induced leading to the accumulation of
peptides, which are predominately or exclusively ADP-ribo-
sylated. An exception from the general down-regulation/ab-
sence of ADP-ribosylation was the detected up-regulation of
LIG3 and RFC1, which are involved in DNA repair. The func-
tion of ARTD1 and PARylation to promote the genotoxic
stress response is well studied (5). DNA repair proteins, e.g.
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XRCC1, are recruited to the sites of DNA damage by binding
to PAR chains (39–41). It is thus not clear, why LIG3 and
RFC1 are ADP-ribosylated at mild oxidative stress.
The observed variations in the intensities of the PAR signal
observed already at 10 M H2O2 with LC-MS/MS for PAR (15)
seems mainly because of the increased length of PAR chains
on pre-MARylated proteins (scenario i) and not because of the
increase of newly modified protein (i.e. de novo ADP-ribosyl-
ation (scenario ii) or an increased number of modified mole-
cules of the same proteins (scenario iii, supplemental Fig.
S2D)). At mid H2O2 concentration (i.e. 62 M H2O2), induction
of ADP-ribosylation according to scenario ii and iii occurs,
while at high H2O2 concentrations (i.e.  250 M H2O2), the
increase in PAR signal is because of PAR elongation. Thus,
flexible PAR elongation at low and high H2O2 concentrations
seems to allow a faster signaling in order to precisely and
quickly respond to oxidative stress. The molecular mecha-
nism regulating the transition between the different response
phases remains to be further investigated.
Overall, the presented results show that it is possible to
evaluate the changes in the level of ADP-ribosylation in oxi-
dative stress using label-free quantification and targeted PRM
approaches. Moreover, the developed PRM method was
used to assess the levels of ADP-ribosylation in two ovarian
cancer cell lines. We noted differences already in the basal
ADP-ribosylome. At basal conditions, 10 proteins (including
11 ADP-ribosylated peptides) were detected in ovarian cancer
cells, including three histone H2B variants (Fig. 3B). In human
somatic cells, 13 H2B variants with only minor amino acid
differences (usually 2–5 amino acids) were identified (42).
Most H2B variants have a serine-and-threonine-to-alanine (S/
T-A) conversion in their sequence. Moreover, different cancer
cell lines were shown to differentially express certain H2B vari-
ants (42), indicating that these variants are essential for tumor-
igenesis. H2B E2 modification is one of the most abundant
ADP-ribosylation sites and can be already detected in untreated
cells. We detected H2B to be ADP-ribosylated at position 2 in all
variants. In HeLa cells, we did not observe any differences in the
level of H2B variants at various degrees of oxidative stress. In
the PARPi resistant cell line SKOV3, the level of H2B variant K
was significantly up-regulated in comparison to A2780. The role
of H2B variants and their PTMs is increasingly being studied,
e.g. the phosphorylation of histone variant H2B3B at S36 was
shown to regulate cellular stress responses (43).
The PARPi sensitive A2780 cells showed an up-regulation
of several ADP-ribosylated proteins under basal conditions
(i.e. YY1, RFC1 and C11orf58), which correlated with higher
protein levels of ARTD1 in these cells. Interestingly, these
ADP-ribosylated proteins were not detected in HeLa cells
under basal conditions, indicating that ARTD1 is more active
in A2780. Moreover, we observed that A2780 cells have a
significantly higher level of H2O2-induced ADP-ribosylated
peptides compared with SKOV3 cells, which also correlated
with the abundance of ARTD1 in these cells. Moreover, in
both ovarian cancer cells the induction of ADP-ribosylation
was observed already at 16 M, whereas in HeLa cells ADP-
ribosylatoin could be detected only at 64 M H2O2. The ob-
served concentration difference could be explained by dif-
ferential expression and activation of enzymes involved in
cellular ADP-ribosylation (e.g. different activities of PAR-de-
grading enzymes) or enzymes participating in the antioxida-
tive response (e.g. catalases).
Because ARTD1 is the prime activated nuclear ART upon
H2O2 treatment, the quantitative identification of ADP-ribosy-
lated proteins allows to indirectly estimate the ARTD1 activity
in the cells. Several previous studies provided a correlation
between high ARTD1 expression levels and poor treatment
outcome (40–42). However, certain cancer types, e.g. chronic
leukemia, did not show the same correlation (43). Thus, to
understand the role of ARTD1 in PARPi sensitivity, it is impor-
tant to apply the developed analytical methods to patient
tumor biopsies with high and low ARTD1 expression.
Taken together, we defined the oxidative stress-induced
ADP-ribosylome for different H2O2 concentrations and vari-
ous cell types in a qualitative and quantitative manner. The
identified quantitative changes should be further validated for
their predictive power as potential markers of oxidative stress
conditions or as predictors of PARPi treatment outcome.
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